Join

Compare · GNOM vs RICE

GNOM vs RICE

Side-by-side comparison of Global X Genomics & Biotechnology ETF (GNOM) and Rice Acquisition Corp. (RICE): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both GNOM and RICE operate in n/a (n/a), so they compete in similar markets.
  • RICE carries a market cap of $536.2M.
  • RICE has more recent analyst coverage (1 ratings vs 0 for GNOM).
MetricGNOMRICE
Company
Global X Genomics & Biotechnology ETF
Rice Acquisition Corp.
Price
$45.67-1.72%
$18.23+0.52%
Market cap
-
$536.2M
1M return
+7.03%
-
1Y return
+40.78%
-
Sector
n/a
n/a
Industry
n/a
n/a
Exchange
NASDAQ
NYSE
IPO
n/a
2020
News (4w)
0
0
Recent ratings
0
1
GNOM

Global X Genomics & Biotechnology ETF

The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.

RICE

Rice Acquisition Corp.

Rice Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Carnegie, Pennsylvania.

Latest GNOM

No recent items for Global X Genomics & Biotechnology ETF.

Latest RICE